Nafiseh Askari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nafiseh Askari has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Faegheh Farhadi
Herbal and Traditional Medicines Research Center, Institute of pharmaceutical Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Mandana Jafari
Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Pouria Rahmanian-Devin
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Vafa Baradaran Rahimi
Patient Safety Research Center, Clinical Research Institute Mashhad University of Medical Sciences Mashhad Iran
1 shared publication - Vahid Reza Askari
Patient Safety Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 25 January 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (1) , 57
Mechanistic insights on lycopene usage against diabetes and associated complications
Lycopene is a tetraterpene compound belonging to carotenoids that are widely present in tomatoes and similar products. It is known as a powerful anti-oxidant and a non-provitamin A carotenoid. Lycopene has been found to effectively improve diabetes mellitus and its complications, such as cardiac complications, disorders caused by oxidative stress, and liver and neurological disorders. Furthermore, free radicals have been shown to disrupt the action of insulin by changing the physical state of the target cell membrane, while carotenoids improve insulin secretion and function in blood sugar regulation by neutralizing free radicals. It, therefore, seems that targeted clinical studies are needed to investigate the therapeutic effect of lycopene against metabolic disorders induced by diabetes. This review aims to summarize information on the sources and potential uses of lycopene and the possible mechanisms involved in the reduction of the above diseases. Its protective effects, in terms of toxicity and safety, are also discussed. The literature sources used in this review were PubMed, Google Scholar, Scopus, and Web of Science databases.
- 25 January 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (1) , 57
Mechanistic insights on lycopene usage against diabetes and associated complications
Lycopene is a tetraterpene compound belonging to carotenoids that are widely present in tomatoes and similar products. It is known as a powerful anti-oxidant and a non-provitamin A carotenoid. Lycopene has been found to effectively improve diabetes mellitus and its complications, such as cardiac complications, disorders caused by oxidative stress, and liver and neurological disorders. Furthermore, free radicals have been shown to disrupt the action of insulin by changing the physical state of the target cell membrane, while carotenoids improve insulin secretion and function in blood sugar regulation by neutralizing free radicals. It, therefore, seems that targeted clinical studies are needed to investigate the therapeutic effect of lycopene against metabolic disorders induced by diabetes. This review aims to summarize information on the sources and potential uses of lycopene and the possible mechanisms involved in the reduction of the above diseases. Its protective effects, in terms of toxicity and safety, are also discussed. The literature sources used in this review were PubMed, Google Scholar, Scopus, and Web of Science databases.